Cargando…

Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson’s disease

BACKGROUND: Retinoic acid (RA) is a biologically active derivative of vitamin A. Previous studies have demonstrated that RA has protective effects against damage caused by H(2)O(2) or oxygen-glucose deprivation in mesangial and PC12 cells. Pretreatment with 9-cis-retinoic acid (9cRA) reduced infarct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Lian-Hu, Shen, Hui, Diaz-Ruiz, Oscar, Bäckman, Cristina M, Bae, Eunkyung, Yu, Seong-Jin, Wang, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523975/ https://www.ncbi.nlm.nih.gov/pubmed/23040108 http://dx.doi.org/10.1186/1471-2202-13-120

Ejemplares similares

9-cis retinoic acid induces neurorepair in stroke brain
por: Yu, Seong-Jin, et al.
Publicado: (2017)

The Crucial Roles of Pitx3 in Midbrain Dopaminergic Neuron Development and Parkinson’s Disease-Associated Neurodegeneration
por: Wang, Xin, et al.
Publicado: (2023)

Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson’s disease
por: Wu, Kuo-Jen, et al.
Publicado: (2023)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Post-surgical treatment of thyroid carcinoma in dogs with retinoic acid 9 cis improves patient outcome
por: Castillo, V., et al.
Publicado: (2016)

Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration
por: Tsika, Elpida, et al.
Publicado: (2014)

TFE3-Mediated Autophagy is Involved in Dopaminergic Neurodegeneration in Parkinson’s Disease
por: He, Xin, et al.
Publicado: (2021)

Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson’s disease
por: Peng, Qinyu, et al.
Publicado: (2022)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

NMDA Receptors on Non-Dopaminergic Neurons in the VTA Support Cocaine Sensitization
por: Luo, Yu, et al.
Publicado: (2010)

Developmental pathways linked to the vulnerability of adult midbrain dopaminergic neurons to neurodegeneration
por: Prakash, Nilima
Publicado: (2022)

miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson’s disease
por: Hu, Yong-Bo, et al.
Publicado: (2019)

Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson’s disease
por: Dionísio, Pedro A., et al.
Publicado: (2019)

Metabolomics research on potential role for 9‐cis‐retinoic acid in breast cancer progression
por: Wu, Jing, et al.
Publicado: (2018)

Dual effects of 9-cis retinoic acid on ACTH-dependent hyperplastic adrenal tissues
por: Pecori Giraldi, Francesca, et al.
Publicado: (2021)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Dopaminergic neurodegeneration in the substantia nigra is associated with olfactory dysfunction in mice models of Parkinson’s disease
por: Yuan, Yu, et al.
Publicado: (2023)

Ironing out Neurodegeneration: New Class of Lipids Promotes Ferroptosis in Dopaminergic Neurons
por: Kostenko, Anastasiia, et al.
Publicado: (2023)

Morphological hallmarks of dopaminergic neurodegeneration are associated with altered neuron function in Caenorhabditis elegans
por: Clark, Andrew S., et al.
Publicado: (2023)

Roles of FGF20 in dopaminergic neurons and Parkinson's disease
por: Itoh, Nobuyuki, et al.
Publicado: (2013)

Post-treatment with Posiphen Reduces Endoplasmic Reticulum Stress and Neurodegeneration in Stroke Brain
por: Yu, Seong-Jin, et al.
Publicado: (2020)

Mechanism of miR-132-3p Promoting Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease
por: Gong, Xin, et al.
Publicado: (2022)

Interleukin-4 Protects Dopaminergic Neurons In vitro but Is Dispensable for MPTP-Induced Neurodegeneration In vivo
por: Hühner, Laura, et al.
Publicado: (2017)

Particulate Matter Exacerbates the Death of Dopaminergic Neurons in Parkinson’s Disease through an Inflammatory Response
por: Choi, Dabin, et al.
Publicado: (2022)

Effects of all-trans and 9-cis retinoic acid on differentiating human neural stem cells in vitro
por: Kubickova, Barbara, et al.
Publicado: (2023)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
por: Zhang, Siyan, et al.
Publicado: (2020)

Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease Models
por: Neal, Matthew L., et al.
Publicado: (2023)

Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson’s Disease
por: Kolacheva, Anna, et al.
Publicado: (2022)

Fluorescence microscopy-based sensitive method to quantify dopaminergic neurodegeneration in a Drosophila model of Parkinson’s disease
por: Ayajuddin, Mohamad, et al.
Publicado: (2023)

Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration
por: Valenzuela, Rita, et al.
Publicado: (2016)

Molecular Regulation in Dopaminergic Neuron Development. Cues to Unveil Molecular Pathogenesis and Pharmacological Targets of Neurodegeneration
por: Volpicelli, Floriana, et al.
Publicado: (2020)

Modelling α-Synuclein Aggregation and Neurodegeneration with Fibril Seeds in Primary Cultures of Mouse Dopaminergic Neurons
por: Tourville, Aurore, et al.
Publicado: (2022)

Dopaminergic Neuronal Imaging in Genetic Parkinson's Disease: Insights into Pathogenesis
por: McNeill, Alisdair, et al.
Publicado: (2013)

Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease
por: Song, Juhyun, et al.
Publicado: (2016)

Induced dopaminergic neurons: A new promise for Parkinson’s disease
por: Xu, Zhimin, et al.
Publicado: (2017)

Moxibustion Protects Dopaminergic Neurons in Parkinson's Disease through Antiferroptosis
por: Huang, Zifeng, et al.
Publicado: (2021)

Optogenetic induction of alpha-synuclein aggregation in human dopaminergic neurons to model Parkinson’s disease pathology
por: Ra, Eun A., et al.
Publicado: (2023)

Differential and antagonistic effects of 9- cis -retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro
por: Pettersson, F, et al.
Publicado: (2000)

Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat
por: Ponthan, F, et al.
Publicado: (2001)

All-trans- and 9-cis-retinoic acid: potent direct inhibitors of primitive murine hematopoietic progenitors in vitro
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_ft07lpoj38k9co7pk1epvv8atv